4.3 Article

First trimester serum neutrophil gelatinase-associated lipocalin in gestational diabetes

Journal

DIABETIC MEDICINE
Volume 26, Issue 12, Pages 1293-1295

Publisher

WILEY
DOI: 10.1111/j.1464-5491.2009.02830.x

Keywords

gestational diabetes; lipocalin; neutrophil gelatinase-associated lipocalin

Ask authors/readers for more resources

Aims Neutrophil gelatinase-associated lipocalin (NGAL) is highly expressed in damaged epithelia, during inflammation and cardiovascular disease. Soluble NGAL was measured in women who subsequently developed gestational diabetes. Methods From a cohort of 908 pregnant outpatients who participated in a screening programme for Down's syndrome at 9-12 weeks of gestation, we considered all 41 women with a singleton pregnancy, who developed gestational diabetes in the previous 12 months, and a control group of 82 normal pregnancies. Circulating NGAL and insulin resistance by homeostasis model assessment ratio (HOMA-IR) were determined in the first trimester. Results Median serum NGAL concentrations were higher in the gestational diabetes group [51.3 ng/ml (39.8-66.1 ng/ml)] compared with the control group [17.8 ng/ml (15.5-20.9 ng/ml)] (P < 0.001) and positively correlated with HOMA-IR (P < 0.001). Conclusions In the first trimester, circulating NGAL was significantly increased in women who subsequently developed gestational diabetes compared with the control group. Diabet. Med. 26, 1293-1295 (2009).

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available